Pioneer of prostate cancer: past, present and the future of FOXA1

Prostate cancer is the most commonly diagnosed non-cutaneous cancers in North American men. While androgen deprivation has remained as the cornerstone of prostate cancer treatment, resistance ensues leading to lethal disease. Forkhead box A1 (FOXA1) encodes a pioneer factor that induces open chromat...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Mona, Zhou, Stanley, Cai, Changmeng, Lupien, Mathieu, He, Housheng Hansen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815845/
https://www.ncbi.nlm.nih.gov/pubmed/32946061
http://dx.doi.org/10.1007/s13238-020-00786-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815845/
https://www.ncbi.nlm.nih.gov/pubmed/32946061
http://dx.doi.org/10.1007/s13238-020-00786-8

Ejemplares similares